Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,265 public trials 1,195 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

NCT04181788

Conditions
Advanced Malignancies, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Beijing Cancer hospital Beijing, Beijing Municipality, China
  • Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China
  • Nanjing Drum Tower Hospital Nanjing, Jiangsu, China
  • Huashan Hospital Affiliated to Fudan University Shanghai, Shanghai Municipality, China
View all 49 locations
View Trial Details
Completed

A Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive Cancer

NCT03194893

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Centre Francois Baclesse Caen, France
  • Centre Georges François Leclerc Dijon, France
View all 29 locations
View Trial Details
Completed

A Study of Autogene Cevumeran (RO7198457) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors

NCT03289962

Conditions
Bladder Cancer, Breast Diseases, Breast Neoplasms, +48 more
Locations
  • HonorHealth Research Institute ? Bisgrove Scottsdale, Arizona, United States
  • The Los Angeles Clinic Los Angeles, California, United States
  • UCSF Comprehensive Cancer Ctr San Francisco, California, United States
  • Stanford Cancer Center Stanford, California, United States
View all 33 locations
View Trial Details
Completed

A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer

NCT04619797

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • UCLA Los Angeles, California, United States
  • PIH Health Whittier Hospital Whittier, California, United States
  • SCRI Florida Cancer Specialists South Fort Myers, Florida, United States
  • SCRI Florida Cancer Specialists North St. Petersburg, Florida, United States
View all 127 locations
View Trial Details
Completed

Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15

NCT05546476

Conditions
Anorexia, Body Weight, Body Weight Changes, +34 more
Locations
  • CARTI Conway Conway, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
  • CARTI North Little Rock North Little Rock, Arkansas, United States
  • CARTI Stuttgart Stuttgart, Arkansas, United States
View all 78 locations
View Trial Details

Related conditions